51 results
DEF 14A
IMCR
Immunocore Holdings plc
12 Apr 24
Definitive proxy
4:20pm
GENERAL MEETING OF SHAREHOLDERS
RESOLUTION 7 AUTHORIZATION FOR THE AUDIT COMMITTEE TO DETERMINE THE U.K. STATUTORY AUDITORS’ REMUNERATION … meeting of shareholders
FOR
To authorize the Audit Committee to determine our U.K. statutory auditors’ remuneration for the year ending December 31
PRE 14A
IMCR
Immunocore Holdings plc
2 Apr 24
Preliminary proxy
4:45pm
OFFICE UNTIL THE CONCLUSION OF THE NEXT ANNUAL GENERAL MEETING OF SHAREHOLDERS
RESOLUTION 7 AUTHORIZATION FOR THE AUDIT COMMITTEE TO DETERMINE THE U.K … of the next annual general meeting of shareholders
FOR
To authorize the Audit Committee to determine our U.K. statutory auditors’ remuneration for the year
10-K
2023 FY
IMCR
Immunocore Holdings plc
28 Feb 24
Annual report
7:33am
and are subject to audit and verification procedures that could result in material changes in the final data.
If we fail to comply with manufacturing regulations … remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary data we
10-K
2023 FY
EX-31.2
IMCR
Immunocore Holdings plc
28 Feb 24
Annual report
7:33am
evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors
10-K
2023 FY
EX-31.1
IMCR
Immunocore Holdings plc
28 Feb 24
Annual report
7:33am
evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors
8-K
x7drrqlq0d rxo449
29 Jan 24
Immunocore Announces Proposed Convertible Senior Notes Offering
5:06pm
6-K
EX-99.2
3bjxdlw n29sdvkv3j
7 Nov 23
Current report (foreign)
7:09am
6-K
EX-99.2
3s1b35jj
10 Aug 23
Current report (foreign)
8:28am
6-K
EX-99.2
rk61vlob7 9ure208
10 May 23
Current report (foreign)
7:27am
6-K
EX-99.1
hsadh4649xrsb7a
18 Apr 23
Current report (foreign)
4:13pm
6-K
EX-99.2
k56t2hn4cwas1
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
6-K
EX-99.4
osg8ypby1w4e3g
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
424B7
ks27thvvpvih5629uh
30 Sep 22
Prospectus with selling stockholder info
4:15pm
424B5
tjx22cjp5o j3ms
9 Sep 22
Prospectus supplement for primary offering
4:23pm
6-K
EX-99.3
2qefidm4e1wb6l3jrw
10 Aug 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
8:00am
6-K
EX-99.2
paibu
10 Aug 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
8:00am
6-K
EX-99.1
2o4n89491nzqyozhm94
20 Jul 22
Securities Purchase Agreement
4:06pm
6-K
EX-99.2
2wnk04
20 Jul 22
Securities Purchase Agreement
4:06pm
6-K
i3bzg
9 Jun 22
Immunocore Appoints Siddharth Kaul to its Board of Directors
4:12pm
6-K
EX-99.1
ufojx3ah fjfa
9 Jun 22
Immunocore Appoints Siddharth Kaul to its Board of Directors
4:12pm